Q3 2025 Holdings
Filed 2025-11-14 | 68 holdings | $165.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $8.6M | 131,016 | 5.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.8M | 142,417 | 4.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.9M | 133,087 | 4.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.4M | 443,547 | 3.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $6.1M | 98,182 | 3.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.0M | 7,852 | 3.6% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $5.4M | 1,439,604 | 3.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $5.4M | 101,996 | 3.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $4.5M | 156,072 | 2.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.3M | 28,362 | 2.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.1M | 61,356 | 2.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.0M | 273,661 | 2.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.8M | 94,400 | 2.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $3.8M | 156,917 | 2.3% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $3.7M | 18,100 | 2.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $3.6M | 104,507 | 2.2% |
| CVS Health Corp(CVS) | COM | 126650100 | $3.3M | 43,600 | 2.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.3M | 48,445 | 2.0% |
| Natera Inc(NTRA) | COM | 632307104 | $3.0M | 18,650 | 1.8% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $2.9M | 229,962 | 1.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.8M | 6,358 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.8M | 173,439 | 1.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.8M | 6,645 | 1.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.8M | 58,579 | 1.7% |
| Vaneck ETF Trust(PPH)Call | PHARMACEUTCL ETF | 92189F692 | $2.7M | 30,000 | 1.6% |
| Travere Therapeutics IncCall | CALL | 89422G907 | $2.6M | 110,000 | 1.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.6M | 158,622 | 1.5% |
| Geron Corp(GERN) | COM | 374163103 | $2.5M | 1,858,354 | 1.5% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.4M | 745,305 | 1.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.3M | 9,000 | 1.4% |
| Glaukos Corp(GKOS) | COM | 377322102 | $2.2M | 27,143 | 1.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $2.1M | 94,235 | 1.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.1M | 88,024 | 1.3% |
| Novo-Nordisk A SCall | CALL | 670100905 | $1.9M | 35,000 | 1.2% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $1.9M | 163,658 | 1.2% |
| Cencora Inc(COR) | COM | 03073E105 | $1.9M | 6,000 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.8M | 117,783 | 1.1% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $1.8M | 46,900 | 1.1% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $1.8M | 2,000,000 | 1.1% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $1.6M | 2,000,000 | 1.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $1.6M | 7,955 | 1.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.4M | 120,644 | 0.9% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $1.4M | 39,900 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $1.4M | 18,600 | 0.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.3M | 22,090 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.3M | 178,084 | 0.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.3M | 100,036 | 0.8% |
| Liquidia CorporationPut | PUT | 53635D952 | $1.2M | 53,000 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.2M | 451,699 | 0.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $1.2M | 292,770 | 0.7% |